InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
4
T+90 hit rate
82%
T+90 mean return
+7.4%
Across 11 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Del Carmen Jeffrey, Directeur Commercial. Director active across 1 company, notably Catalyst Pharmaceuticals, INC.. Aggregated, 19 reports have been published. Breakdown: 0 buy · 4 sells. Total volume traded: €1.1m. Activity tracked since 19 August 2022. The latest transaction was disclosed on 3 March 2025 (Cession). Regulator: SEC (Form 4). All data is free.
Declarations19 total
8,667 sharesCommon Stock, par value $0.001 per shareSEC:0001161697-25-000489:0
3,839 sharesCommon Stock, par value $0.001 per shareSEC:0001161697-25-000489:1
30,423 shares@ US$22.8945.8% of flowCommon stock, par value $0.001 per shareSEC:0001161697-25-000084:0
10,667 sharesCommon stock, par value $0.001 per shareSEC:0001161697-25-000065:0
8,667 sharesCommon stock, par value $0.001 per shareSEC:0001161697-24-000537:0
3,839 sharesCommon stock, par value $0.001 per shareSEC:0001161697-24-000537:1
8,039 sharesCommon stock, par value $0.001 per shareSEC:0001161697-24-000499:0
6,058 shares@ US$18.447.0% of flowCommon stock, par value $0.001 per shareSEC:0001161697-24-000341:0
7,541 shares@ US$16.077.6% of flowCommon stock, par value $0.001 per shareSEC:0001161697-24-000262:0
10,667 sharesCommon stock, par value $0.001 per shareSEC:0001161697-24-000098:0
8,666 sharesCommon stock, par value $0.001 per shareSEC:0001161697-23-000643:0
10,000 sharesCommon stock, par value $0.001 per shareSEC:0001161697-23-000384:0
20,983 shares@ US$2.243.0% of flowCommon stock, par value $0.001 per shareSEC:0001161697-23-000201:0
10,666 sharesCommon stock, par value $0.001 per shareSEC:0001161697-23-000125:0
120,000 shares@ US$2.8623.1% of flowCommon stock, par value $0.001 per shareSEC:0001161697-22-000547:0
14,140 shares@ US$14.0513.5% of flowCommon stock, par value $0.001 per shareSEC:0001161697-22-000405:0
10,000 sharesCommon stock, par value $0.001 per shareSEC:0001161697-22-000328:0
10,000 sharesCommon stock, par value $0.001 per shareSEC:0001161697-21-000316:0
10,000 sharesCommon stock, par value $0.001 per shareSEC:0001161697-21-000316
19 of 19 declarations
About Del Carmen Jeffrey
Jeffrey Del Carmen is the Chief Commercial Officer at Catalyst Pharmaceuticals, Inc. He is responsible for commercial strategy and sales growth, contributing to the development of the company.
